Literature DB >> 23728397

Hepatic myelopathy with spastic paraparesis: report of two cases and review of the literature.

Sana Ben Amor1, Mohamed Zakaria Saied, Mohamed Salah Harzallah, Sofiene Benammou.   

Abstract

PURPOSE: The present report illustrates two men aged for 59 and 43 years, respectively, who presented with slowly progressive spastic paraparesis. STUDY
DESIGN: Two case reports and review of literature.
METHODS: The patent's history, clinical examination, biology, magnetic resonance imaging (MRI) findings and treatment are reported. We also discuss the pathogenesis and various treatment options.
RESULTS: Neurologic examination showed spastic paraparesis without other neurological disorders. MRI of the spinal cord and brain were normal. Cytologic examination of cerebrospinal fluid from each patient was normal. Hemogram disclosed a pancytopenia. Partial thromboplastin time was prolonged. Liver function tests revealed raised serum bilirubin, normal alanine aminotransferase and aspartate aminotransferase, reduced total protein and albumin. Plasma ammonia was elevated. Blood vitamin B12 and folate values were in normal ranges. Serum antibodies to human T cell lymphotropic virus, human immunodeficiency virus, syphilis and hepatitis C virus were absent. Hepatitis B virus antibody assay was positive. The electromyographic evaluation for second motor neuron involvement was also normal. Endoscopy revealed esophageal varices and a spleno-renal shunt.
CONCLUSIONS: Hepatic myelopathy remains a default diagnosis assigned only after the exclusion of other causes of spastic paraparesis and partial transverse myelopathy. An accurate history, along with appropriate imaging and laboratory findings, is crucial.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23728397     DOI: 10.1007/s00586-013-2828-z

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  10 in total

Review 1.  Hepatic myelopathy after splenorenal shunting: report of one case and review of the literature.

Authors:  P Yengue; M Adler; H Bouhdid; N Mavroudakis; M Gelin; N Bourgeois
Journal:  Acta Gastroenterol Belg       Date:  2001 Apr-Jun       Impact factor: 1.316

2.  Myelopathy in Hepatic Cirrhosis.

Authors:  S S Pant; A N Bhargava; M M Singh; P C Dhanda
Journal:  Br Med J       Date:  1963-04-20

3.  Portal-systemic myelopathy after transjugular intrahepatic portosystemic shunt creation: report of four cases.

Authors:  M Q Wang; M D Dake; Z P Cui; Z Q Wang; Y A Gao
Journal:  J Vasc Interv Radiol       Date:  2001-07       Impact factor: 3.464

4.  Hepatic myelopathy with spastic paraparesis.

Authors:  Ufuk Utku; Talip Asil; Kemal Balci; Ilkay Uzunca; Yahya Celik
Journal:  Clin Neurol Neurosurg       Date:  2004-11-10       Impact factor: 1.876

Review 5.  Disorders of the spinal cord and roots.

Authors:  Lionel Ginsberg
Journal:  Pract Neurol       Date:  2011-08

6.  Hepatic myelopathy. Case report with review of the literature.

Authors:  J V Campellone; D Lacomis; M J Giuliani; F J Kroboth
Journal:  Clin Neurol Neurosurg       Date:  1996-08       Impact factor: 1.876

Review 7.  Use of model for end-stage liver disease exception points for early liver transplantation and successful reversal of hepatic myelopathy with a review of the literature.

Authors:  Cary Caldwell; Norman Werdiger; Sofia Jakab; Michael Schilsky; Antonios Arvelakis; Sanjay Kulkarni; Sukru Emre
Journal:  Liver Transpl       Date:  2010-07       Impact factor: 5.799

Review 8.  Hepatic myelopathy: a rare complication of portacaval shunt.

Authors:  G Mendoza; J Marti-Fàbregas; J Kulisevsky; A Escartín
Journal:  Eur Neurol       Date:  1994       Impact factor: 1.710

9.  Liver transplantation improves hepatic myelopathy: evidence by three cases.

Authors:  Karin Weissenborn; Uwe J F Tietge; Martin Bokemeyer; Bahram Mohammadi; Ulriue Bode; Michael P Manns; Martin Caselitz
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

10.  The role of liver transplantation in the treatment of hepatic myelopathy: case report with review of the literature.

Authors:  B Qu; C Liu; L Guo; Y Yang; J H Li; L Yu; Y Lv
Journal:  Transplant Proc       Date:  2009-06       Impact factor: 1.066

  10 in total
  8 in total

1.  Letter to the editor concerning "Hepatic myelopathy with spastic paraparesis: report of two cases and review of the literature" by S. Ben Amor et al. (Eur Spine J. 2013, Jun 1).

Authors:  Raffaele Nardone; Stefan Golaszewski; Yvonne Höller; Francesco Brigo; Eugen Trinka
Journal:  Eur Spine J       Date:  2013-08-21       Impact factor: 3.134

2.  Answer to the letter to the editor of R. Nardone et al. concerning "Hepatic myelopathy with spastic paraparesis: report of two cases and review of the literature" (by Sana Ben Amor et al. (2013), Eur Spine J; DOI 10.1007/s00586-013-2828-z).

Authors:  S Ben Amor; M Z Saied; M S Harzallah; S Benammou
Journal:  Eur Spine J       Date:  2013-08-21       Impact factor: 3.134

3.  Spinal cord injury causes chronic liver pathology in rats.

Authors:  Andrew D Sauerbeck; J Lukas Laws; Veera V R Bandaru; Phillip G Popovich; Norman J Haughey; Dana M McTigue
Journal:  J Neurotrauma       Date:  2014-10-21       Impact factor: 5.269

Review 4.  Spinal cord involvement in patients with cirrhosis.

Authors:  Raffaele Nardone; Yvonne Höller; Monica Storti; Piergiorgio Lochner; Frediano Tezzon; Stefan Golaszewski; Francesco Brigo; Eugen Trinka
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 5.  Management of Neurologic Manifestations in Patients with Liver Disease.

Authors:  José M Ferro; Pedro Viana; Patrícia Santos
Journal:  Curr Treat Options Neurol       Date:  2016-08       Impact factor: 3.598

6.  Alcoholic Myelopathy and Nutritional Deficiency.

Authors:  Haruki Koike; Tomohiko Nakamura; Shohei Ikeda; Mie Takahashi; Yuichi Kawagashira; Masahiro Iijima; Masahisa Katsuno; Gen Sobue
Journal:  Intern Med       Date:  2017-01-01       Impact factor: 1.271

7.  Benefits of Early Treatment for Patients with Hepatic Myelopathy Secondary to TIPS: A Retrospective Study in Northern China.

Authors:  Hongwei Zhao; Zhendong Yue; Lei Wang; Zhenhua Fan; Fuliang He; Xiaoqun Dong; Fuquan Liu
Journal:  Sci Rep       Date:  2018-10-12       Impact factor: 4.379

8.  The effect of fecal microbiota transplantation on Hepatic myelopathy: A case report.

Authors:  Lin Sun; Jun Li; Li-Li Lan; Xiao-An Li
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.